Induction of Cyclooxygenase-2 Accounts for Restraint Stress-Induced Oxidative Status in Rat Brain
The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
Cyclooxygenase (COX) is the rate-limiting enzyme in the metabolism of arachidonic acid into prostanoids. Although it is constitutively expressed in brain neurons, the inducible isoform (COX-2) is also upregulated in pathological conditions such as seizures, ischemia or some degenerative diseases. To assess whether COX-2 is regulated after stress, we have used adult male Wistar rats, some of which were immobilized during 6 h. An increase in PGE2 concentration occurs in brain cortex after 2-6 h of the onset of stress as well as an enhancement of COX-2 protein. Immunohistochemical studies indicate that COX-2 is expressed in the cortex and hippocampus after stress in cells with morphology of neurons. Administration of PDTC (150 mg/kg), an inhibitor of the transcription factor NF-kappaB or MK-801 (0.2 mg/kg), an N-methyl-D-aspartate receptor blocker, prevents both stress-induced increase in COX-2 activity and protein levels, suggesting an implication of these factors in the mechanism by which stress induces COX-2 in brain. To assess if COX-2 accounts for the oxidative status seen in brain after stress, a group of animals were i.p. injected with NS-398, a specific COX-2 inhibitor 1 h prior to the onset of stress. NS-398 (5 mg/kg) decreases stress-induced malondialdehyde accumulation in cortex as well as prevents the stress-induced oxidation of glutathione. Finally, NS-398 reduced Ca2+-independent inducible nitric oxide synthase (iNOS, NOS-2) activity and lowered the stress-induced accumulation of NO metabolite levels in cortex. These effects of NS-398 seem to be due to the specific inhibition of COX-2, since it has no effect on stress-induced corticosterone release, glutamate release, and NF-kappaB activation. These findings are discussed as possible damaging and/or adaptive roles for stress-induced COX-2 in the brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Acute stress increases NF-κB activity (Madrigal et al., 2001), intracellular TNF-α-convertase activity, extracellular TNF-α (Madrigal et al., 2002), and prostaglandin E2 and COX-2 levels (Madrigal et al., 2003) in the cortex.”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as Madrigal et al., 2003
In the citing paper
“In support of this hypothesis, restraint stress and other physical stressors were shown to induce inflammatory mediators (e.g., iNOS, TNF-α, COX-2, PGE2, IL-1β, and CD14), reduce immunoregulatory proteins (e.g., CD200R) and trigger microglia proliferation in the rodent brain (147–152).”
From The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain (2014) · cites this paper as [151]
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077 · cited 1×
“It was calculated by first reducing NO3 into NO2 in the presence of Cd (Cortas and Wakid, 1990) and NO2 was determined by a colorimetric assay based on the Griess reaction (Green et al, 1982) in a Thermomaxs microplate reader (Molecular Devices).”
MethodProtective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733 · cited 1×
“A question of particular interest is the possibility that the changes seen would be a feature not of the deleterious effects of stress, but of some potentially reversible type of adaptive plasticity, as proposed by McEwen (1998).”
BackgroundChemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672 · cited 10×
“Administration of NS-398 (5 mg/kg i.p.) 1 h before the onset of stress prevented stress-induced increase in both parameters, MDA and oxidised glutathione (Figure 4a and b, respectively).”
BackgroundInfluentialSchreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179 · cited 1×
“A modified procedure based on the method of Schreiber et al (1989) was used.”
Method[70] Determination of glutathione and glutathione disulfide in biological samples
Anderson, M. E. (1985) · Methods in Enzymology · doi:10.1016/s0076-6879(85)13073-9 · Cited by 2,748 · cited 1×
“These levels were measured as previously described (Anderson, 1985).”
MethodVane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734 · cited 1×
“Indeed, the two catalytic steps of COX-2, COX and peroxidase, are associated with the production of reactive oxygen species and, similarly to NOS-2, COX-2 could act as a source of superoxide for ONOO formation (Vane et al, 1998).”
BackgroundCyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506 · cited 1×
“In this vein, the implication of constitutive COX-2 expression in the brain and its upregulation by stress could also be physiological (reviewed in Dubois et al, 1998), a question that deserves further consideration.”
BackgroundRole of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212 · cited 1×
“The oligonucleotide sequence corresponding to the consensus NF-kB binding site (nucleotides 978 to 952) of the murine NOS-2 promoter was 50TGCTAGGGGGA TTTTCCCTCTCTCTGT30 (Xie et al, 1994).”
BackgroundHippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932 · cited 1×
“A plausible consequence of this is the volume reduction that has been described in these two brain structures in chronically depressed patients and other stress-related disorders (Sheline et al, 1996; Koenen et al, 2001; Cotter et al, 2002).”
BackgroundLindroth, P., & Mopper, K. (1979) · Analytical Chemistry · doi:10.1021/ac50047a019 · Cited by 1,837 · cited 1×
“Analysis of glutamate in plasma was performed by HPLC with fluorimetric detection (Perkin-Elmer Binary LC Pump 250 and Fluorescence Detector LC 240) (Lindroth and Mopper, 1979).”
Method
Cited by
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
“Increased activity of COX-2 results in the generation of free radicals and O&NS (Kuehl and Egan, 1980; Madrigal et al., 2003; Vesce et al., 2007).”
BackgroundNuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior
Koo, J. W., Russo, S. J., Ferguson, D., Nestler, E. J., & Duman, R. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910658107 · Cited by 607
Kubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J., & Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.026 · Cited by 443
Restraint stress in biobehavioral research: Recent developments
Buynitsky, T., & Mostofsky, D. I. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.05.004 · Cited by 426
“Recent theory and experimentation by McEwen and his associates (Conrad et al., 1996, 1999; Dhabhar et al., 1997; Lehman et al., 1991; Lucas et al., 2007; Luine et al., 1994; Magariños and McEwen, 1995a, 1995b; Wood et al., 2003), Sapolsky et al. (2000) and others have energized research activities far beyond the mode…”
InfluentialThe Stressed CNS: When Glucocorticoids Aggravate Inflammation
Sorrells, S. F., Caso, J. R., Munhoz, C. D., & Sapolsky, R. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.032 · Cited by 425
The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain
Bellavance, M.-A., & Rivest, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00136 · Cited by 419
Nair, A., & Bonneau, R. H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.09.012 · Cited by 392
Stress as a neuroinflammatory condition in brain: Damaging and protective mechanisms
García-Bueno, B., Caso, J. R., & Leza, J. C. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.04.001 · Cited by 280
Self-citationGould, T. D., Quiroz, J. A., Singh, J., Zarate, C. A., & Manji, H. K. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001518 · Cited by 238
Bufalino, C., Hepgul, N., Aguglia, E., & Pariante, C. M. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.04.009 · Cited by 228
Quiroz, J. A. (2004) · Molecular Interventions · doi:10.1124/mi.4.5.6 · Cited by 206
Ki, Y.-W., Park, J. H., Lee, J. E., Shin, I. C., & Koh, H. C. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.02.003 · Cited by 203
Caso, J. R., Pradillo, J. M., Hurtado, O., Leza, J. C., Moro, M. A., & Lizasoain, I. (2008) · Stroke · doi:10.1161/strokeaha.107.498212 · Cited by 193
Self-citationRegulatory and Mechanistic Actions of Glucocorticoids on T and Inflammatory Cells
Liberman, A. C., Budziñski, M. L., Sokn, C., Gobbini, R. P., Steininger, A., & Arzt, E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00235 · Cited by 181
Benzo(a)pyrene‐induced acute neurotoxicity in the F‐344 rat: role of oxidative stress
Saunders, C. R., Das, S. K., Ramesh, A., Shockley, D. C., & Mukherjee, S. (2006) · Journal of Applied Toxicology · doi:10.1002/jat.1157 · Cited by 164
“2006; 26: 427–438 DOI: 10.1002/jat B(a)P (Madrigal et al., 2003).”
InfluentialRivat, C., Becker, C., Blugeot, A., Zeau, B., Mauborgne, A., Pohl, M., & Benoliel, J.-J. (2010) · Pain · doi:10.1016/j.pain.2010.05.031 · Cited by 159
“Cyclooxygenase-2 (COX-2), for example, may be responsible for stress-induced brain damage [16,24].”
BackgroundGárate, I., García-Bueno, B., Madrigal, J. L., Bravo, L., Berrocoso, E., Caso, J. R., Micó, J. A., & Leza, J. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-151 · Cited by 165
“The induction of COX-2 in the CNS by stress and the increase in the PGE2 levels in the brain cortex are well documented phenomena [48,49] of significant importance in experimental models of depression and in depressive disorders [50], bearing in mind that PGE2, in turn, stimulates production of proinflammatory cytokin…”
BackgroundSelf-citationHarvey, B. H., Stein, D. J., Oosthuizen, F., Brand, L., & Wegener, G. (2003) · Psychopharmacology · doi:10.1007/s00213-004-1836-4 · Cited by 160
“An increase in the expression of iNOS has been noted to occur in limbic brain regions following restraint stress in rats (Madrigal et al. 2001, 2003).”
BackgroundMethodInfluentialGuo, J.-Y., Li, C.-Y., Ruan, Y.-P., Sun, M., Qi, X.-L., Zhao, B.-S., & Luo, F. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.076 · Cited by 148
Nonsteroidal Anti-Inflammatory Treatment Prevents Delayed Effects of Early Life Stress in Rats
Brenhouse, H. C., & Andersen, S. L. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.006 · Cited by 126
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation
Zoppi, S., Perez‐Nievas, B. G., Madrigal, J. L. M., Manzanares, J., Leza, J. C., & García‐Bueno, B. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.214 · Cited by 137
“NF-k NF-k B activation elicits the expression and activity of proinflammatory enzymatic sources, such as inducible nitric oxide (NO) synthase (NOS-2), and cyclo-oxygenase-2 (COX-2), among others (Madrigal et al , 2001a, 2003).”
BackgroundSelf-citationMangiferin decreases inflammation and oxidative damage in rat brain after stress
Márquez, L., García-Bueno, B., Madrigal, J. L. M., & Leza, J. C. (2012) · European Journal of Nutrition · doi:10.1007/s00394-011-0252-x · Cited by 111
Self-citationGarcía‐Bueno, B., Madrigal, J. L. M., Lizasoaín, I., Moro, M. Á., Lorenzo, P. L., & Leza, J. C. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.007 · Cited by 117
Self-citationIncreased plasma nitric oxide level associated with suicide attempt in depressive patients
Kim, Y., Paik, J., Lee, S.-W., Yoon, D., Han, C., & Lee, B.-H. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.008 · Cited by 109
Targeting fatty acid metabolism in glioblastoma
Miska, J. M., & Chandel, N. S. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163448 · Cited by 105
García-Bueno, B., Madrigal, J. L. M., Pérez-Nievas, B. G., & Leza, J. C. (2008) · Endocrinology · doi:10.1210/en.2007-0482 · Cited by 97
Self-citationChanges in behaviour and cytokine expression upon a peripheral immune challenge
Bay-Richter, C., Janelidze, S., Hallberg, L., & Brundin, L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.060 · Cited by 109
Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation
Im, J., Kim, D., Paik, S., & Han, P. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.06.001 · Cited by 98
Wang, H., Hitron, I. M., Iadecola, C., & Pickel, V. M. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhi008 · Cited by 87
“In addition, the levels of basal expression of COX-2 in cortical neurons is relatively low and widely distributed (Madrigal et al., 2003).”
BackgroundBradesi, S. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01491.x · Cited by 87
Wieck, A., Andersen, S. L., & Brenhouse, H. C. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.11.012 · Cited by 92
“However, COX-2 is a multifunctional signaling molecule that could lead to PVB loss via increased inflammatory cytokine activity, or from oxidative stress or excitotoxicity that are separate from cytokine activity (Madrigal et al., 2003; Schiavone et al., 2009; Takadera et al., 2002).”
Dhir, A., Naidu, P. S., & Kulkarni, S. K. (2007) · Seizure · doi:10.1016/j.seizure.2007.05.016 · Cited by 87
Increased Plasma Nitric Oxide Metabolites in Suicide Attempters
Lee, B.-H., Lee, S.-W., Yoon, D., Lee, H.-J., Yang, J.-C., Shim, S.-H., Kim, D.-H., Ryu, S.-H., Han, C., & Kim, Y.-K. (2006) · Neuropsychobiology · doi:10.1159/000092542 · Cited by 88
Carrasco, E., Casper, D., & Werner, P. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21425 · Cited by 84
“Oxidative stress can increase inflammatory activity and, conversely, inflammation is known to cause oxidative stress (Madrigal et al., 2003; Teismann et al., 2003; Liao et al., 2007).”
BackgroundOosthuizen, F., Wegener, G., & Harvey, B. H. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.1.2.109.61049 · Cited by 84
“Similarly, increased expression of nNOS (De Oliviera et al 2000) and iNOS (Madrigal et al 2001, 2003) has been noted to occur in limbic brain regions following acute restraint stress in rats.”
BackgroundCui, B., Li, K., Gai, Z., She, X., Zhang, N., Xu, C.-X., Chen, X., An, G., Ma, Q., & Wang, R. (2015) · Scientific Reports · doi:10.1038/srep12943 · Cited by 81
Pardon, M. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.007 · Cited by 82
Lima, M. D. M. S., Reksidler, A. B., Zanata, S. M., Machado, H. B., Tufik, S., & Vital, M. A. B. F. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.016 · Cited by 76
Northrop, N. A., & Yamamoto, B. K. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9391-y · Cited by 75
“COX is increased in the brain by physical and psychological stressors (Yamagata et al. 1993; Madrigal et al. 2003) and environmental stress potentiates METH toxicity (Tata and Yamamoto 2007).”
BackgroundChronic intermittent cold stress sensitizes neuro-immune reactivity in the rat brain
Girotti, M., Donegan, J. J., & Morilak, D. A. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.02.008 · Cited by 70
“COX2 expression can be induced in the brain by acute stress (Madrigal et al., 2003), and is associated with increased lipid peroxidation and nitric oxide levels, as well as memory deficits that are attenuated by COX inhibitors (Madrigal et al., 2003; Dhir et al., 2006).”
BackgroundJangra, A., Dwivedi, S., Sriram, C. S., Gurjar, S. S., Kwatra, M., Sulakhiya, K., Baruah, C. C., & Lahkar, M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.047 · Cited by 73
Zhu, X., Cheng, Y.-Q., Du, L., Li, Y., Zhang, F., Guo, H., Liu, Y.-W., & Yin, X.-X. (2015) · Phytotherapy Research · doi:10.1002/ptr.5254 · Cited by 66
“Diabetic nephropathy (DN) is one of the most severe diabetic microangiopathies, characterized by persistent albuminuria, mesangial matrix expansion, glomerular extracellular matrix accumulation, glomerular basement membrane thickening, and glomerular sclerosis (Mogensen, 1976;Makino et al., 2006).”
BackgroundAshdown, H. F., Poole, S., Boksa, P., & Luheshi, G. N. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00274.2006 · Cited by 65
Parul, P., Mishra, A., Singh, S., Singh, S., Tiwari, V., Chaturvedi, S., Wahajuddin, M., Palit, G., & Shukla, S. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.017 · Cited by 69
Dhir, A., Padi, S. S. V., Naidu, P. S., & Kulkarni, S. K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.01.064 · Cited by 64
Relationship between cyclooxygenase‐2 and nitric oxide synthase‐2 in rat cortex after stress
Madrigal, J. L. M., García‐Bueno, B., Moro, M. A., Lizasoain, I., Lorenzo, P., & Leza, J. C. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02888.x · Cited by 64
Self-citationLi, Y., Shen, J.-D., Li, J., Wang, R., Jiao, S., & Yi, L. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.09.007 · Cited by 64
“A 2–6 h of immobilization stress caused an enhancement of COX-2 protein expression in cortex and hippocampus (Madrigal et al., 2003).”
BackgroundThe neuroendocrine control of the innate immune system in health and brain diseases
Bellavance, M., & Rivest, S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01129.x · Cited by 60
Harrison, E. L., & Baune, B. T. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.31 · Cited by 58
Candelario-Jalil, E., Akundi, R. S., Bhatia, H. S., Lieb, K., Appel, K., Muñoz, E., Hüll, M., & Fiebich, B. L. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.01.003 · Cited by 59
“Since COX-2 expression is in part dependent on redox-sensitive transcriptional events (Fiebich et al., 2000b; Kim et al., 2000; Madrigal et al., 2003), and previous evidences indicate that ascorbic acid reduces COX-2 expression under some conditions (Sanchez-Moreno et al., 2003; Han et al., 2004),…”
BackgroundTabassum, R., Vaibhav, K., Shrivastava, P., Khan, A., Ahmed, M. E., Ashafaq, M., Khan, M. B., Islam, F., Safhi, M. M., & Islam, F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.09.015 · Cited by 64
“Furthermore, NO triggers the COX-2 to release more inflammatory prostaglandins and IL-1β and TNF-α (Nédélec et al., 2001; Madrigal et al., 2003).”
BackgroundKumari, B., Kumar, A., & Dhir, A. (2007) · PubMed · Cited by 61
Glucocorticoids and Inflammation: A Double-Headed Sword in Depression?
Horowitz, M. A., Zunszain, P. A., Anacker, C., Musaelyan, K., & Pariante, C. M. (2013) · Modern Trends in Psychiatry · doi:10.1159/000343980 · Cited by 57
Matsuwaki, T., Kayasuga, Y., Yamanouchi, K., & Nishihara, M. (2005) · Endocrinology · doi:10.1210/en.2005-1056 · Cited by 60
Zheng, G., Zhang, X., Chen, Y., Zhang, Y., Luo, W., & Chen, J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.077 · Cited by 66
Litteljohn, D., Mangano, E. N., & Hayley, S. P. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06371.x · Cited by 54
“…involving exposure to pesticides or DA toxins have revealed enhanced microglial activity and elevated levels of oxidative factors and pro-inflammatory cytokines (Mogi et al., 1994a, b, 1996; Mandel et al., 2000; Nagatsu et al., 2000; Gao et al., 2002; Depino et al., 2003; Purisai et al., 2007).”
BackgroundMaeda, K., & Tsukamura, H. (2006) · Endocrinology · doi:10.1210/en.2005-1523 · Cited by 52
Pérez-Nievas, B. G., García-Bueno, B., Caso, J. R., Menchén, L., & Leza, J. C. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.04.011 · Cited by 51
Self-citationWalia, V., Chaudhary, S. K., & Kumar Sethiya, N. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2020.104939 · Cited by 51
Seo, J., Lee, K.-W., Kim, T., Baek, I., Im, J., & Han, P. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.035 · Cited by 55
Dhull, D. K., Jindal, A., Dhull, R. K., Aggarwal, S., Bhateja, D., & Padi, S. S. V. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9583-6 · Cited by 51
“2003) which is the important mediator of neuronal injury (Madrigal et al. 2003).”
BackgroundOgłodek, E. A., & Just, M. J. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.06.001 · Cited by 51
Brain Protection in Schizophrenia, Mood and Cognitive Disorders
Ritsner, M. S. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5 · Cited by 51
The role of tumor necrosis factor-alpha in stress-induced worsening of cerebral ischemia in rats
Caso, J. R., Lizasoain, I., Lorenzo, P., Moro, M. A., & Leza, J. C. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.009 · Cited by 45
Self-citationLlorens-Martín, M., Jurado-Arjona, J., Bolós, M., Pallas-Bazarra, N., & Ávila, J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.12.019 · Cited by 43
“Although GCs inhibit microglial cell activity in vitro, they increase microglial proliferation in vivo granule .019 (Nair and Bonneau, 2006; Madrigal et al., 2003).”
Emad, S., Qadeer, S., Sadaf, S., Batool, Z., Haider, S., & Perveen, T. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.11.009 · Cited by 44
Mehranfard, N., Ghasemi, M., Rajabian, A., & Ansari, L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22820 · Cited by 46
“Activation of the COX pathway may result in oxidative [199] N. Mehranfard et al. stress [148].”
BackgroundGarcía‐Bueno, B., Madrigal, J. L. M., Lizasoaín, I., Moro, M. Á., Lorenzo, P. L., & Leza, J. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2195-5 · Cited by 48
“…metabolites such as PGJ2 close a negative feedback loop on COX-2 expression, whereas in activated stages such as stress, COX-2 results activated—with production of its main product—PGE2, which closes a positive feedback loop on COX-2, as it has been found to occur in stress (Madrigal et al. 2003b).”
BackgroundResultInfluentialSelf-citationGerecke, K. M., Kolobova, A., Allen, S., & Fawer, J. L. (2013) · Brain Research · doi:10.1016/j.brainres.2013.02.027 · Cited by 37
Oxidant/antioxidant imbalance is an inherent feature of depression
Talarowska, M. E., Szemraj, J., Berk, M., Maes, M. H. J., & Gałecki, P. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0454-5 · Cited by 37
“According to Vaccarino et al. [23], a raised level of MPO may be considered a biomarker of inflammation in the course of rDD. COX-2 COX-2 inhibition restricts the formation of reactive oxygen species [38].”
BackgroundSerrats, J., Grigoleit, J., Alvarez‐Salas, E., & Sawchenko, P. E. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.003 · Cited by 41
The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease
Han, Q.-W., Yuan, Y., & Chen, N. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109745 · Cited by 39
Effects of Noradrenaline on Neuronal NOS2 Expression and Viability
Madrigal, J. L. M., Russo, C. D., Gavrilyuk, V., & Feinstein, D. L. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.885 · Cited by 37
“In vitro induction of stress (23), oxidative insults (29), and proinflammatory factors (1).”
Self-citationHamza, R. Z., Al‐Salmi, F. A., & El‐Shenawy, N. S. (2019) · PeerJ · doi:10.7717/peerj.7460 · Cited by 40
“Madrigal et al. (2003) reported that COX-2 has some important brain functions as a synaptic activity, remembrance consolidation, functional hyperemia, and neuroinflammation.”
Hayley, S. P., Mangano, E. N., Strickland, M., & Anisman, H. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.03.015 · Cited by 37
MPP+-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress
Hsieh, Y., Mounsey, R. B., & Teismann, P. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0660-8 · Cited by 36
“Oxidative stress can increase inflammatory activity and, conversely, inflammation is known to cause oxidative stress (Liao et al. 2007; Madrigal et al. 2003; Teismann et al. 2003a).”
BackgroundKumar, A., Garg, R., Gaur, V., & Kumar, P. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.004 · Cited by 35
Novaes, L. S., dos Santos, N. B., Dragunas, G., Perfetto, J. G., Leza, J. C., Scavone, C., & Munhoz, C. D. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.09.037 · Cited by 37
Self-citationZhou, J., Wu, Z., & Zhao, P. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101097 · Cited by 34
“An early study showed that restraint stress for 2 e 6 h can increase the expression of COX-2 in the cerebral cortex and hippocampus [137].”
Kumar, A., Sharma, S., Prashar, A., & Deshmukh, R. R. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0414-4 · Cited by 33
“Both COX and LOX pathways have been demonstrated to contribute to the development of oxidative stress and neuroinflammation (Candelario-Jalil et al. 2003; Madrigal et al. 2003; Pepicelli et al. 2002; Pratico 2002; Pratico et al. 2004).”
BackgroundMéndez-Cuesta, L. A., Márquez‐Valadez, B., de la Cruz, V. P., Briones, C. E., Galván‐Arzate, S., Álvarez-Ruíz, Y., Maldonado, P. D., Santana-Martínez, R. A., Santamaría, A., & Carrillo‐Mora, P. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00738.x · Cited by 33
Functional Polymorphism of Cyclooxygenase-2 Gene (G–765C) in Depressive Patients
Gałecki, P., Florkowski, A., Bieńkiewicz, M., & Szemraj, J. (2010) · Neuropsychobiology · doi:10.1159/000317284 · Cited by 32
Morgan, A., Kondev, V., Bedse, G., Báldi, R., Marcus, D. J., & Patel, S. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100190 · Cited by 32
Shavit, Y., Weidenfeld, J., Dekeyser, F., Fish, G., Wolf, G., Mayburd, E., Meerson, Y., & Beilin, B. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.003 · Cited by 33
Austin, K. W., Ameringer, S., & Cloud, L. J. (2016) · Parkinson s Disease · doi:10.1155/2016/9869712 · Cited by 35
“Activation of NF-kB pathways also results in the production of cyclooxygenase-2 (COX-2), an enzyme involved in prostaglandin mediated inflammatory responses [33].”
BackgroundHosseini, N., Kourosh‐Arami, M., Nadjafi, S., & Ashtari, B. (2022) · Current Protein and Peptide Science · doi:10.2174/1389203723666220823151326 · Cited by 29
Khalaj, L., Nejad, S. C., Mohammadi, M., Zadeh, S. S., Pour, M. H., Ahmadiani, A., Khodagholi, F., Ashabi, G., Alamdary, S. Z., & Samami, E. (2013) · Brain Research · doi:10.1016/j.brainres.2013.06.041 · Cited by 28
“…is associated with neuroinflammation (Madrigal et al., 2002; García-Bueno et al., 2005), leading to negative outcomes such as oxidative stress (Madrigal et al., 2003), worsening of experimental stroke (Caso et al., 2008), and the onset of inflammatory diseases (cardiovascular, neurological,…”
BackgroundMehri, S., Barangi, S., Zamiri, E., & Karimi, G. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01936-9 · Cited by 27
A COX/5-LOX Inhibitor Licofelone Revealed Anticonvulsant Properties Through iNOS Diminution in Mice
Payandemehr, B., Khoshneviszadeh, M., Varastehmoradi, B., Gholizadeh, R., Bahremand, T., Attar, H., Bahremand, A., & Dehpour, A. R. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1669-z · Cited by 25
“COX or LOX are highly involved in pathological conditions such as seizure and neurodegenerative disease possibly via up-regulation of iNOS [52].”
Yeung, P. K. K., Lai, A. K. W., Son, H. J., Zhang, X., Hwang, O., Chung, S. S. M., & Chung, S. K. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.11.008 · Cited by 29
The Anti-Stress Effect of Mentha arvensis in Immobilized Rats
Tian, W., Akanda, M. R., Islam, A., Yang, H.-D., Lee, S.-C., Lee, J., Kim, S.-K., Choi, Y., Im, S.-Y., & Park, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020355 · Cited by 25
“Certain inflammatory mediators such as COX-2 are involved in the physiological dysfunction of brain tissue [65].”
BackgroundResultJørgensen, A., Maigaard, K., Wörtwein, G., Hageman, I., Henriksen, T., Weimann, A., Möller, P., Loft, S. H., Hau, J., Poulsen, H. E., et al. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.08.016 · Cited by 25
“Various measures of cerebral oxidative stress, e.g. protein or lipid oxidation markers, have been found to be increased in animal models of psychological stress (Fontella et al., 2005; Madrigal et al., 2003).”
Kumar, A., Kaur, G., & Rinwa, P. (2014) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(14)60089-3 · Cited by 23
Wu, X., Liu, C., Wang, J., Guan, Y., Song, L., Chen, R., & Gong, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03641-w · Cited by 24
Maheshwari, A., Badgujar, L., Phukan, B., Bodhankar, S. L., & Thakurdesai, P. A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.030 · Cited by 22
Evaluation of sesamol and buspirone in stress induced anxiety in mice
Kumar, A., Kaur, G., Kalonia, H., & Rinwa, P. (2013) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.106435 · Cited by 21
Schaalan, M. F., & Nassar, N. N. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0486-2 · Cited by 21
“On one hand, chronic CORT exposure increases mitochondrial electron transport chain activity and nitric oxide production and on the other hand, reduces endogenous antioxidants defense systems [38–40].”
BackgroundMéndez-Cuesta, L. A., Márquez‐Valadez, B., de la Cruz, V. P., Maldonado, P. D., Santana-Martínez, R. A., Briones, C. E., Galván‐Arzate, S., Carrillo‐Mora, P., & Santamarı́a, A. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00691.x · Cited by 20
Gonçalves, F. M., Freitas, A. E., Peres, T. V., Rieger, D. K., Ben, J., Maestri, M., Costa, A. P., Tramontina, A. C., Gonçalves, C. A., Rodrigues, A. L. S., et al. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1150-9 · Cited by 19
Fekri, K., Nayebi, A. M., Sadigh‐Eteghad, S., Farajdokht, F., & Mahmoudi, J. (2020) · Neurochemical Journal · doi:10.1134/s181971242002004x · Cited by 19
Metadata
- Authors
- Madrigal, J. L. M., Moro, M. A., Lizasoain, I., Lorenzo, P., Fernández, A. P., Rodrigo, J., Boscá, L., & Leza, J. C.
- Affiliations
- Universidad Complutense de Madrid (ES)
- Instituto Cajal (ES)
- Corresponding author
- Leza, Juan C
- Venue
- Neuropsychopharmacology
- Published
- 2003-02-26
- Volume
- 28
- Issue
- 9
- Pages
- 1579-1588
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2332934002
- Cited by
- 155
- References
- 77
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 3 · 2023: 3 · 2022: 9 · 2021: 2 · 2020: 5 · 2019: 8 · 2018: 7 · 2017: 1 · 2016: 5 · 2015: 5 · 2014: 6 · 2013: 8 · 2012: 10
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministerio de Ciencia y Tecnología
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- cyclooxygenase-2, restraint stress, oxidative stress, brain, prostanoids, prostaglandin E2, NF-κB, NMDA receptor, MK-801, pyrrolidine dithiocarbamate, NS-398, inducible nitric oxide synthase, nitric oxide, malondialdehyde, glutathione oxidation, hippocampus, cerebral cortex, corticosterone, stress adaptation
- MeSH terms
- Animals, Antioxidants, Brain, Brain Chemistry, Calcium, Cell Nucleus, Corticosterone, Cytosol, Drug Interactions, Glutathione, Immobilization, Immunohistochemistry, Isoenzymes, Male, Malondialdehyde, Neurons, Nitrobenzenes, Proline, Prostaglandin-Endoperoxide Synthases, Stress, Physiological, Sulfonamides, Thiocarbamates, Time Factors, Blotting, Western, Dinoprostone, Dizocilpine Maleate, NF-kappa B, Cyclooxygenase Inhibitors, Rats, Wistar, Neuroprotective Agents, Nitric Oxide Synthase, Electrophoretic Mobility Shift Assay, Cell Size, Rats, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.